Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts near

Steve Marso, Verdiva Bio CMO July 23, 2026 06:30 AM EDT PeopleR&DGLP-1 drugs Ex­clu­sive: Obe­si­ty biotech Ver­di­va hires ex-Met­sera CMO as cru­cial read­outs near Elizabeth Cairns Senior biopharma journalist Long-act­ing obe­si­ty pill de­vel­op­er Ver­di­va Bio has a new chief med­ical of­fi­cer, and he comes from a biotech that was look­ing at very sim­i­lar tech­nol­o­gy — … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER